STEMON Inc. is a specialized cell reprogramming company that developed Entr® (ultrasound-directed permeation of Environmental transition-guided cellular reprogramming), an original technology for cell reprogramming with only ultrasound and environmental factors used without genes used, unlike conventional methods. STEMON Inc. recently developed UltraRepro®, the world's first equipment for automating Entr® core technology, and suggested alternatives to overcome a lot of problems such as the low efficiency, stability, and immune rejection of conventional cell therapies. In addition, STEMON Inc. succeeded in mass production of Reprosome, various customized exosomes induced from dermal fibroblasts using the Entr® automation system, and is currently promoting the development of treatments for various intractable diseases, including immune and respiratory diseases. Accordingly, this company will develop into an innovative company that develops cell therapy products in the future.
moreEXHIBIT
COMPANY INTRODUCTION
STEMON Inc. is a specialized cell reprogramming company that developed Entr® (ultrasound-directed permeation of Environmental transition-guided cellular reprogramming), an original technology for cell reprogramming with only ultrasound and environmental factors used without genes used, unlike conventional methods. STEMON Inc. recently developed UltraRepro®, the world's first equipment for automating Entr® core technology, and suggested alternatives to overcome a lot of problems such as the low efficiency, stability, and immune rejection of conventional cell therapies. In addition, STEMON Inc. succeeded in mass production of Reprosome, various customized exosomes induced from dermal fibroblasts using the Entr® automation system, and is currently promoting the development of treatments for various intractable diseases, including immune and respiratory diseases. Accordingly, this company will develop into an innovative company that develops cell therapy products in the future.